Key Record Dates Identifier: NCT03217812
Brief Title: A Study of VELCADE (Bortezomib) Melphalan-Prednisone (VMP) Compared to Daratumumab in Combination With VMP (D-VMP), in Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-Dose Therapy (Asia Pacific Region)

First Submitted : July 13, 2017
First Submitted that Met QC Criteria : July 13, 2017
First Posted : July 14, 2017

Last Update Submitted that Met QC Criteria : February 19, 2019
Last Update Posted : February 20, 2019